Financial Summary (All financials)
| In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| Revenues | 42.9 | 29.0 | 23.9 | 24.6 | 10.2 |
| Revenue growth | 47.8% | 21.6% | -2.7% | 141.5% | |
| Cost of goods sold | 6.1 | 5.8 | 6.0 | 5.8 | 4.0 |
| Gross profit | 36.9 | 23.3 | 17.8 | 18.8 | 6.2 |
| Gross margin | 85.9% | 80.1% | 74.7% | 76.4% | 60.6% |
| Selling, general and administrative | 12.9 | 10.8 | 7.7 | | |
| Research and development | 15.7 | 10.5 | 5.5 | 6.1 | 3.5 |
| General and administrative | | | | 5.8 | 6.0 |
| EBIT | 7.1 | 0.7 | 3.5 | 5.6 | -4.6 |
| EBIT margin | 16.5% | 2.5% | 14.6% | 22.7% | -45.0% |
| Pre-tax income | 7.4 | 0.8 | 3.5 | 1.2 | -4.5 |
| Income taxes | -17.2 | 0.0 | 0.8 | -0.4 | 0.0 |
| Tax rate | | 3.3% | 23.0% | | 0.0% |
| Net income | 24.6 | 0.8 | 2.7 | 20.1 | -4.5 |
| Net margin | 57.3% | 2.7% | 11.3% | 81.8% | -44.5% |
| |
| Diluted EPS | $1.48 | $0.05 | $0.18 | $1.34 | ($0.30) |
| Shares outstanding (diluted) | 16.6 | 15.6 | 15.3 | 15.0 | 15.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|